Page last updated: 2024-11-05

acridine mustard

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acridine mustard: ICR 170 was heading 1975-95 (see under NITROGEN MUSTARD COMPOUNDS 1975-90); ACRIDINE MUSTARD was see ICR 170 1981-95; use ICR-170 (NM) to search ICR 170 1975-95 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8971
CHEBI ID21183
SCHEMBL ID5341589
MeSH IDM0242719

Synonyms (30)

Synonym
9-(3-(ethyl(2-chloroethyl)amino)propylamino)-6-chloro-2-methoxyacridine dihydrochloride
1,3-propanediamine, n-(2-chloroethyl)-n'-(6-chloro-2-methoxy-9-acridinyl)-n-ethyl-, dihydrochloride
ccris 1091
6-chloro-9-(3-(ethyl-2-chloroethyl)aminopropylamino)-2-methoxyacridine dihydrochloride
6-chloro-9-((3-((2-chloroethyl)ethylamino)propyl)amino)-2-methoxyacridine dihydrochloride
acridine, 6-chloro-9-(3-(n-(2-chloroethyl)-n-ethylamino)propylamino)-2-methoxy-, dihydrochloride
1,3-propanediamine, n-(2-chloroethyl)-n'-(6-chloro-2-methoxy-9-acridinyl)-n-ethyl-, 2hcl
einecs 205-675-7
n-(2-chloroethyl)-n'-(6-chloro-2-methoxyacridin-9-yl)-n-ethylpropane-1,3-diamine dihydrochloride
icr 170
CHEBI:21183
n-(2-chloroethyl)-n'-(6-chloro-2-methoxy-9-acridinyl)-n-ethyl-1,3-propanediamine dihydrochloride
acridine mustard
icr-170
146-59-8
0i3a3407t2 ,
unii-0i3a3407t2
FT-0631845
1,3-propanediamine, n1-(2-chloroethyl)-n3-(6-chloro-2-methoxy-9-acridinyl)-n1-ethyl-, hydrochloride (1:2)
icr-170h
SCHEMBL5341589
6-chloro-9-(3-n-(2-chloroethyl)ethylamino]propylamino-2-methoxyacridine dihydrochloride
DTXSID8073893
2-methoxy-6-chloro-9-[3-[ethyl(2-chloroethyl)amino]propylamino]acridine dihydrochloride
6-chloro-9-[3-n-(2-chloroethyl)ethylamino]propylamino-2-methoxyacridine dihydrochloride
trimethylolpropanetris(2-mercaptoacetate)
Q26840876
n1-(6-chloro-2-methoxyacridin-9-yl)-n3-(2-chloroethyl)-n3-ethylpropane-1,3-diamine dihydrochloride
n'-(2-chloroethyl)-n-(6-chloro-2-methoxyacridin-9-yl)-n'-ethylpropane-1,3-diamine;dihydrochloride
n1-(6-chloro-2-methoxyacridin-9-yl)-n3-(2-chloroethyl)-n3-ethylpropane-1,3-diaminedihydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Six different treatments of conidial suspensions of H-12 with ICR-170 were used to obtain dose-response curves for inactivation of conidia as well as the overall induction of ad-3 forward mutations using a direct method based on pigment accumulation rather than a requirement for adenine."( Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive leth
de Serres, FJ; Malling, HV, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
intercalatorA role played by a chemical agent which exhibits the capability of occupying space between DNA base pairs due to particular properties in size, shape and charge. Intercalation of chemical compounds in DNA helix can result in replication errors (shift, mutation) or DNA damages.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
acridines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (53.13)18.7374
1990's9 (28.13)18.2507
2000's4 (12.50)29.6817
2010's0 (0.00)24.3611
2020's2 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.93 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]